c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis

Schneider J, J. Schneider, Jimenez E, E Jimenez, Rodriguez F, F Rodriguez, del Tanago JG, J G del Tanago
Oncology reports · 1998 · vol. 5(1) , pp. 49–52 · doi:10.3892/or.5.1.49 · PMID:9458291
Other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-07 ⓘ

This study found c-myc and nm23 expression in 53.3% and 43.7% of endometriosis samples, respectively, while c-erb-B2 and p53 were undetectable.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-02 · read from full text ⓘ

This retrospective pilot study examined the expression of specific oncogenes and tumor-suppressor genes in tissue samples from sixteen patients with histologically verified pelvic endometriosis. Researchers utilized immunohistochemical analysis on archival paraffin-embedded specimens to detect c-myc, c-erb-B2, nm23, and p53 proteins. The results indicated that c-myc was expressed in 53.3% of cases and nm23 in 43.7%, while c-erb-B2 and p53 reactivity remained undetectable across all tested samples. The authors concluded that the overexpression of c-myc and nm23 may contribute to the pathogenesis of endometriosis, suggesting immuno-histochemistry is a valuable tool for studying oncogenic activation in this condition. This paper is centrally about endometriosis, specifically investigating molecular markers associated with its development.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

We studied the expression of oncogenes and tumor-suppressor genes in human endometriosis in a retrospective pilot study. Sixteen patients with histologically verified pelvic endometriosis at the university-based tertiary care referral center were studied. Immunohistochemical determination of c-myc, c-erb-B2, nm23 and p53 expression in archival, paraffin-embedded pathological samples were used from patients operated upon for pelvic endometriosis. c-myc was expressed in 8/15 cases (53.3%). nm23 was expressed in 7/16 cases (43.7%). c-erb-B2 and p53 reactivity was undetectable in the samples studied. The c-myc oncogene and nm23 are overexpressed in many cases of endometriosis, and may play a still undefined role in its pathogenesis. Immuno-histochemistry is a useful tool for the study of oncogenic activation in this disease.
Full text 3,197 characters · extracted from oa-doi-fallback · click to expand
Print ISSN: 1021-335X Online ISSN: 1791-2431 International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease. International Journal of Oncology is an international journal devoted to oncology research and cancer treatment. Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery. Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine. Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology. International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis. Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology. Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition. Publishes open-access research on using epigenetics to advance understanding and treatment of human disease. An International Open Access Journal Devoted to General Medicine. Article - Authors: - Pages: 49-101|Published online on: January 1, 1998https://doi.org/10.3892/or.5.1.49 - Expand metrics + We studied the expression of oncogenes and tumor-suppressor genes in human endometriosis in a retrospective pilot study. Sixteen patients with histologically verified pelvic endometriosis at the university-based tertiary care referral center were studied. Immunohistochemical determination of c-myc, c-erb-B2, nm23 and p53 expression in archival, paraffin-embedded pathological samples were used from patients operated upon for pelvic endometriosis. c-myc was expressed in 8/15 cases (53.3%). nm23 was expressed in 7/16 cases (43.7%). c-erb-B2 and p53 reactivity was undetectable in the samples studied. The c-myc oncogene and nm23 are overexpressed in many cases of endometriosis, and may play a still undefined role in its pathogenesis. Immuno-histochemistry is a useful tool for the study of oncogenic activation in this disease. Copy and paste a formatted citation Spandidos Publications style Schneider J, Jimenez E, Rodriguez F and del Tanago J: c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.. Oncol Rep 5: 49-101, 1998. APA Schneider, J., Jimenez, E., Rodriguez, F., & del Tanago, J. (1998). c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.. Oncology Reports, 5, 49-101. https://doi.org/10.3892/or.5.1.49 MLA Schneider, J., Jimenez, E., Rodriguez, F., del Tanago, J."c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.". Oncology Reports 5.1 (1998): 49-101. Chicago Schneider, J., Jimenez, E., Rodriguez, F., del Tanago, J."c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.". Oncology Reports 5, no. 1 (1998): 49-101. https://doi.org/10.3892/or.5.1.49

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Erb-b2 Receptor Tyrosine Kinases Genes, erbB-2 Genes, erbB-2 Genes, myc Genes, myc Genes, Tumor Suppressor Genes, Tumor Suppressor Monomeric GTP-Binding Proteins Monomeric GTP-Binding Proteins Nucleoside-Diphosphate Kinase Nucleoside-Diphosphate Kinase Proto-Oncogene Proteins c-myc Transcription Factors Uterine Diseases Biopsy Biopsy Endometriosis Endometriosis Endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-08T06:18:23.926119+00:00
pubmed
last seen: 2026-10-08T22:00:28.864438+00:00
unpaywall
last seen: 2026-10-08T06:33:43.470499+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine